Assessing decisional capacity to consent to electroconvulsive therapy — the Appelbaum & Grisso four-ability framework applied to a specific, high-stakes psychiatric procedure
Understanding is the first and most directly testable of the four abilities in the Appelbaum & Grisso model of decisional capacity (1988, refined into the MacArthur Competence Assessment Tool for Treatment, MacCAT-T). It asks a narrow question: after adequate disclosure, can the patient accurately restate — in their own words — the diagnosis, the nature of the ECT procedure, its expected benefits, its material risks, and the reasonable alternatives, including declining treatment altogether? Understanding is necessary but not sufficient for capacity; a patient can understand facts perfectly and still lack capacity if appreciation, reasoning, or the ability to express a choice is impaired.
Appelbaum & Grisso's framework, now the dominant clinical and legal standard across most jurisdictions, decomposes "capacity to consent" into four discrete, sequentially testable abilities:
1. Understanding — factual comprehension of disclosed information 2. Appreciation — recognition that the information applies to oneself 3. Reasoning — rational manipulation of the information to reach a decision 4. Expressing a choice — communicating a stable, discernible decision
Each ability is assessed independently, typically through a semi-structured interview (the MacCAT-T is the most widely validated instrument), and capacity determination follows weakest-link logic: a clinically meaningful deficit in any single domain can be sufficient to find the patient incapable for the decision at hand, even if the other three domains are intact. Capacity is also decision-specific and time-specific — a patient may lack capacity to consent to ECT today but regain it after acute symptoms improve, and may simultaneously retain capacity for unrelated decisions.
Because ECT is an invasive procedure performed under general anesthesia with a muscle relaxant, disclosure — and therefore the understanding standard — is more demanding than for an oral medication trial. A capacity-adequate understanding of ECT ordinarily includes:
• The diagnosis and indication for which ECT is being recommended (e.g., treatment-resistant major depressive episode, catatonia, severe psychotic depression, or mania with psychosis) • The basic mechanics of the procedure: brief general anesthesia and a muscle relaxant, followed by a carefully controlled electrical stimulus that induces a generalized seizure, with electrodes placed unilaterally or bilaterally • The expected course: typically 6–12 sessions delivered several times per week, with the possibility of maintenance treatments • Material risks: memory disturbance (both anterograde and retrograde, usually transient but occasionally persistent), post-ictal confusion, headache, muscle soreness, and rare anesthesia-related complications • Expected benefits: ECT has among the highest response and remission rates of any treatment for severe, treatment-resistant, or psychotic depression, and can be lifesaving in acute suicidality or catatonia • Reasonable alternatives: continued or adjusted pharmacotherapy, psychotherapy, other neuromodulation options (e.g., transcranial magnetic stimulation), and the alternative of declining treatment entirely
The population for whom ECT is typically indicated is, by the nature of the referral, disproportionately likely to have transient or fluctuating impairments in understanding: severe psychomotor retardation and impaired concentration in profound depression, psychotic depression with disorganized thinking, catatonic stupor, manic distractibility, superimposed delirium (from medical illness, medication effects, or substance withdrawal), pre-existing intellectual disability, low health literacy, or language and interpreter barriers. Crucially, an initial failure to demonstrate understanding is not itself a capacity determination — it is a prompt to improve disclosure (simpler language, written materials, repeated sessions, family involvement where appropriate, professional interpreters) and to reassess before concluding that capacity is genuinely impaired.
Clinical guidelines generally recommend the "teach-back" method — asking the patient to explain the procedure, risks, benefits, and alternatives back in their own words — across more than one session before concluding that understanding is inadequate, since acute psychiatric symptoms, sedating medications, and unfamiliar clinical settings can all transiently depress comprehension without reflecting a stable, decision-relevant incapacity.
Appreciation is the ability that most sharply separates capacity assessment from a simple knowledge quiz. A patient can accurately recite every fact about ECT — the procedure, the risks, the expected benefit — and still lack capacity if they do not believe those facts are true of their own situation. Appreciation failures are most often driven by specific psychiatric symptoms rather than general unintelligence or inattention: anosognosia (lack of insight into having an illness), delusional denial, or nihilistic beliefs that treatment cannot possibly help. Distinguishing "impaired appreciation" from a patient's reasoned skepticism or disagreement with the treating team is the central diagnostic challenge of this domain.
Understanding asks "can the patient state the facts?" Appreciation asks "does the patient believe the facts are true of them, and can they describe realistic consequences of each option for their own life?" A useful bedside probe is to ask the patient to describe, in their own words, what they believe is wrong with them, why the team believes ECT could help, and what they think would happen if they declined treatment. A patient who understands every fact about ECT but insists "there is nothing wrong with me" or "nothing can help me, I am already dead inside" (a nihilistic, sometimes Cotard-like delusion) demonstrates intact understanding with impaired appreciation.
Appreciation deficits are frequently symptom-driven and, like understanding deficits, may be transient: they often improve as the underlying psychiatric episode responds to treatment — which creates the characteristic clinical paradox that the patients most likely to benefit from ECT are sometimes the patients least likely to appreciate that they need it.
A patient who accepts the diagnosis, accepts that ECT is likely to help, but chooses to decline because they weigh the risk of memory loss more heavily than the clinical team does, is exercising intact appreciation and reasoning — they are simply reaching a different value-laden conclusion. Capacity assessment protects a patient's right to make choices the treating team disagrees with, including a well-reasoned refusal of a highly effective treatment. Evaluators are specifically cautioned against conflating "irrational" outcomes with "incapable" processes; the standard is whether the patient can accurately relate the information to their own circumstances, not whether they agree with the recommendation.
Severe psychotic depression can produce mood-congruent delusions (guilt, poverty, somatic, or nihilistic) that directly distort appreciation of both the illness and the proposed treatment. Mania with psychotic features can produce grandiose overestimation of one's own invulnerability or capabilities, leading to denial that any treatment is needed. Catatonia can coexist with retained but inaccessible insight, complicating assessment until communication improves. In each case, appreciation should be reassessed serially rather than judged from a single encounter, and, where possible, corroborated with collateral history from family or prior treatment records to distinguish a stable belief system (e.g., religious or cultural views about treatment) from a delusional distortion caused by the current episode.
Reasoning capacity concerns the process by which a decision is reached, not the outcome. A patient with intact reasoning must be able to logically manipulate the disclosed, personally-relevant information — comparing the expected speed and magnitude of benefit from ECT against the risk of memory disturbance, and weighing both against slower-acting or less effective alternatives — to arrive at a decision that follows coherently from their own stated values. Evaluators are required to assess the logical consistency of the process, not whether they personally agree with the conclusion; a well-reasoned decision to decline ECT must be honored exactly as readily as a well-reasoned decision to accept it.
Reasoning is typically probed by asking the patient to explain the consequences of each option as they see them, and how they compared those consequences to reach their decision: "Walk me through how you decided." A patient with intact reasoning capacity can identify at least the major considerations (likely benefit, likely risk, timeline, alternatives) and describe how they traded them off — even if their final weighting differs from the clinical team's. Formal instruments such as the MacCAT-T score reasoning by asking the patient to generate consequences of each choice, compare options, and produce a decision that logically follows from their own comparison.
Reasoning failures look different from appreciation failures: the patient may accept the diagnosis and accept that ECT could help them personally, yet be unable to hold multiple considerations in mind simultaneously, unable to compare their relative weight, or unable to follow their own comparison through to a stable conclusion.
Severe depression frequently produces marked psychomotor and cognitive slowing that limits working memory and processing speed enough to prevent a patient from comparing more than one consideration at a time, even when each individual fact is understood. Psychotic disorganization (loose associations, tangentiality, thought blocking) can derail a logical comparison mid-stream. Manic flight of ideas can produce a superficially fluent but internally inconsistent chain of reasoning. Severe anxiety or panic occurring during the consent conversation can also transiently impair reasoning independent of any underlying psychotic or mood disorder, and should prompt a calmer, slower re-approach rather than an immediate capacity determination.
The reasoning standard does not require the patient to reach the "correct" or medically preferred decision — only that they can identify, compare, and logically weigh the relevant considerations. Courts and ethics bodies in most jurisdictions are explicit that patients retain the right to make choices a treating team considers unwise, provided the underlying reasoning process is intact; capacity assessment is not a mechanism for enforcing clinician preference.
Because many of the conditions that indicate ECT also slow cognitive processing, evaluators are encouraged to allow additional time, break the disclosure into smaller segments, and reassess across more than one session before concluding that reasoning capacity is genuinely absent rather than merely slowed. A patient who eventually reaches and can explain a coherent, internally consistent comparison — even with substantial support and extra time — demonstrates intact reasoning capacity. A patient who cannot, despite support, hold or compare the relevant considerations across repeated attempts is a stronger candidate for a reasoning-based capacity impairment.
The fourth ability carries the lowest cognitive threshold of the four, but is frequently the most operationally important: can the patient communicate a decision at all, and hold it steady long enough for it to be acted upon? This domain is most vulnerable to catatonia, severe psychomotor retardation, and mutism — conditions in which cognition may be substantially intact but its outward expression is blocked. It is also the domain in which voluntariness must be actively screened: a clearly and consistently expressed choice that has been produced by coercion, undue family pressure, or clinician pressure does not satisfy informed consent even though the "expressing a choice" ability itself is technically intact.
Unlike the first three abilities, expressing a choice does not require the patient to justify or explain their decision — only to communicate one, and to communicate the same one with reasonable consistency over the relevant period. The legal and clinical threshold is intentionally low: a clear verbal statement, a signature, a nod maintained under direct questioning, or another unambiguous and stable signal is generally sufficient. This low threshold exists because the ability to express a choice, standing alone, says nothing about whether the underlying decision was understood, appreciated, or reasoned through — those are assessed separately by the first three abilities.
Catatonia — one of the conditions for which ECT is a first-line, sometimes lifesaving treatment — can present with profound mutism or immobility while leaving comprehension, insight, and reasoning substantially preserved underneath; assessing capacity in these patients often requires waiting for partial symptom relief (sometimes via a lorazepam challenge test) to allow communication before a definitive capacity determination is possible. Severe psychomotor retardation in depression can produce long response latencies that are easily mistaken for refusal or incapacity if the evaluator does not allow adequate time. Rapidly fluctuating mental states (delirium, mixed mood episodes) can produce genuine decisional oscillation — the patient is not being deliberately indecisive, their underlying state is changing from hour to hour — which should prompt serial reassessment rather than a single forced determination.
A stable, clearly expressed choice must still be voluntary to satisfy informed consent. Evaluators should separately probe for coercive pressure: has the patient been told treatment is the only way to be discharged, to regain custody, or to avoid an unrelated adverse consequence? Is a family member or guardian pressuring a particular outcome? Some persistent psychiatric symptoms (severe hopelessness, passive suicidality, or a wish to comply simply to please others) can also produce an outwardly "clear" choice that does not reflect the patient's own voluntary preference. Where coercion or undue pressure is identified, the appropriate response is to address the pressure and re-elicit the choice in a neutral setting — not to treat the originally expressed choice as invalid without further exploration.
The four abilities are synthesized using weakest-link logic: when understanding, appreciation, reasoning, and the ability to express a choice are all clinically adequate, informed consent proceeds directly with the patient as decision-maker. When one or more abilities is impaired, the response depends on urgency and, critically, on whether the cause of impairment is likely reversible. Reversible causes (delirium, oversedation, an acute but treatable psychotic or manic episode, transient catatonic mutism) generally warrant optimization and reassessment before any substitute pathway is invoked. Persistent or emergent impairment triggers jurisdiction-specific legal mechanisms — a substitute decision-maker, an advance directive, a guardianship or tribunal process, or, where life is at immediate risk, an emergency treatment provision.
Because the four abilities test genuinely distinct cognitive and communicative functions, a deficit isolated to a single domain — for example, intact understanding, appreciation, and reasoning but an inability to communicate a stable choice due to catatonic mutism — is generally sufficient on its own to support a finding that the patient currently lacks capacity for this specific decision, even though three of the four abilities are fully preserved. This is why capacity determinations should explicitly document the assessment of each of the four abilities separately, rather than reaching a single global impression; a documented, domain-by-domain record both protects the patient and clarifies exactly what would need to change (e.g., resolution of mutism) before capacity could be reassessed favorably.
Because ECT is typically delivered as a course of multiple sessions over several weeks, many protocols require re-confirmation of ongoing consent capacity at intervals through the course — not only once at the outset — since the underlying psychiatric or medical condition, and therefore capacity itself, can change meaningfully between the first and last session.
A substantial share of apparent incapacity in acutely ill psychiatric and medically ill patients is attributable to reversible confounders rather than a fixed, irreversible deficit: superimposed delirium from infection, metabolic derangement, or substance intoxication/withdrawal; oversedation from benzodiazepines or other CNS-depressant medications; an acute psychotic or manic episode still early in treatment; or a transient catatonic state that improves with a benzodiazepine challenge. Standard practice favors treating or removing these reversible factors, then reassessing capacity, before concluding that a patient permanently lacks capacity for the ECT decision — since a premature determination can unnecessarily transfer a fundamental medical decision away from a patient who would, with appropriate support or timing, be able to make it themselves.
When impairment is not reversible on a clinically relevant timescale, or when urgent treatment cannot wait for optimization, most jurisdictions provide a structured alternative pathway rather than allowing treatment to proceed on the treating clinician's judgment alone. These mechanisms vary substantially by jurisdiction but generally include: a legally authorized substitute decision-maker (spouse, family member, or court-appointed guardian) applying either the patient's previously expressed wishes (substituted judgment) or the patient's best interests; a valid advance directive or psychiatric advance statement completed while the patient had capacity; formal guardianship or a mental health review tribunal / court order, often required specifically for ECT given its invasiveness and historical controversy; and narrowly defined emergency provisions for immediately life-threatening situations (e.g., malignant catatonia, actively life-threatening suicidality) that permit treatment to proceed with an abbreviated authorization process, subject to prompt after-the-fact review.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Optimize & reassess | Treat delirium/oversedation, allow lucid interval, re-run capacity interview | ||
| Advance directive / psychiatric advance statement | Honor previously documented treatment wishes regarding ECT | ||
| Substitute decision-maker / guardian | Legally authorized proxy applies substituted judgment or best-interests standard | ||
| Emergency treatment provision | Abbreviated authorization (e.g., two-physician certification) to proceed without delay |